Ab interno trabecular bypass surgery with iStent for open-angle glaucoma

Cochrane Database of Systematic Reviews

Volumn 2019, Issue 3, 2019, Pages

  Le, Jimmy T ^a   Bicket, Amanda K ^b   Wang, Lin ^a   Li, Tianjing ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AB INTERNO TRABECULAR BYPASS SURGERY; AGE; CLINICAL EFFECTIVENESS; CLINICAL OUTCOME; EVIDENCE BASED MEDICINE; FUNDING; GLAUCOMA SURGERY; HUMAN; INTERMETHOD COMPARISON; INTRAOCULAR PRESSURE; LOW LEVEL LASER THERAPY; META ANALYSIS; MINIMALLY INVASIVE SURGERY; OPEN ANGLE GLAUCOMA; PATIENT DROPOUT; PATIENT SAFETY; PHACOEMULSIFICATION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW; TRABECULECTOMY; UNCERTAINTY; VISION; AGED; FEMALE; GLAUCOMA DRAINAGE IMPLANT; INTRAOCULAR HYPERTENSION; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PROCEDURES; STENT; TRABECULAR MESHWORK; VERY ELDERLY;

ANTIHYPERTENSIVE AGENT; EYE DROPS;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; COMBINED MODALITY THERAPY; FEMALE; GLAUCOMA DRAINAGE IMPLANTS; GLAUCOMA, OPEN-ANGLE; HUMANS; MALE; MIDDLE AGED; OCULAR HYPERTENSION; OPHTHALMIC SOLUTIONS; PHACOEMULSIFICATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STENTS; TRABECULAR MESHWORK;

EID: 85063612894     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD012743.pub2     Document Type: Review

References (82)

1. Fea A, Lacroix G, Ghennadian S, Brogliatti B, Grignolo F,. A prospective, randomized, double blind 15-month pilot study on the efficacy of trabecular stent (iStent) implantation with combined phacoemulsification. American Academy of Ophthalmology 2008: 214. 10544484
2. Fea AM,. Phacoemulsification versus phacoemulsification with micro-bypass stent implantation in primary open-angle glaucoma: randomized double-masked clinical trial. Journal of Cataract and Refractive Surgery 2010; 36 (3): 407 - 12. 10544486
3. Fea AM, Consolandi G, Zola M, Pignata G, Cannizzo P, Lavia C, et al., Micro-bypass implantation for primary open-angle glaucoma combined with phacoemulsification: 4-year follow-up. Journal of Ophthalmology 2015; 2015: 795357. [DOI: org/10.1155/2015/795357 ] 10544485
4. NCT00847158,. A clinical trial of phacoemulsification versus phacoemulsification and the iStent implantation in POAG patients. clinicaltrials.gov/ct2/show/NCT00847158 (first received 9 February 2009). 10544487
5. Fea AM, Belda JI, Rekas M, Junemann A, Chang L, Pablo L, et al., Prospective unmasked randomized evaluation of the iStent inject ((R)) versus two ocular hypotensive agents in patients with primary open-angle glaucoma. Clinical Ophthalmology 2014; 8: 875 - 82. 10544489
6. NCT00913029,. Evaluation of the iStent versus two ocular hypotensive agents in patients with primary open-angle glaucoma (POAG) (SL). clinicaltrials.gov/ct2/show/study/NCT00913029 (first received 3 June 2009). 10544490
7. Fernandez-Barrientos Y, Garcia-Feijoo J, Martinez-de-la-Casa JM, Pablo LE, Fernandez-Perez C, Garcia Sanchez J,. Fluorophotometric study of the effect of the Glaukos trabecular microbypass stent on aqueous humor dynamics. Investigative Ophthalmology and Visual Science 2010; 51 (7): 3327 - 32. 10544492
8. NCT00326066,. A study of the iStent in combo with cataract surgery in newly diagnosed open angle glaucoma or OH patients. clinicaltrials.gov/ct2/show/NCT00326066 (first received 13 May 2006). 10544493
9. Katz LJ, Erb C, Carceller GA, Fea AM, Voskanyan L, Wells JM, et al., Prospective, randomized study of one, two, or three trabecular bypass stents in open-angle glaucoma subjects on topical hypotensive medication. Clinical Ophthalmology 2015; 9: 2313 - 20. 10544495
10. Katz LJ, Erb C, Carceller Guillamet A, Fea AM, Voskanyan L, Giamporcaro JE, et al., Long-term titrated IOP control with one, two, or three trabecular micro-bypass stents in open-angle glaucoma subjects on topical hypotensive medication: 42-month outcomes. Clinical Ophthalmology 2018; 12: 255 - 62. 10544496
11. NCT01517477,. One, two, or three iStents for the reduction of intraocular pressure in open-angle glaucoma subjects. clinicaltrials.gov/ct2/show/NCT01517477 (first received 25 January 2012). 10544497
12. NCT00721968,. Safety and efficacy of the GTS400 stent in conjunction with cataract. clinicaltrials.gov/ct2/show/NCT00721968 (first received 6 March 2014). 10544499
13. Craven ER, Katz LJ, Wells JM, Giamporcaro JE,. Cataract surgery with trabecular micro-bypass stent implantation in patients with mild-to-moderate open-angle glaucoma and cataract: two-year follow-up. Journal of Cataract and Refractive Surgery 2012; 38 (8): 1339 - 45. 10544501
14. NCT00323284,. A study of the trabecular micro-bypass stent in combination with cataract surgery in subjects with open angle glaucoma. clinicaltrials.gov/ct2/show/NCT00323284 (first received 4 October 2012). 10544502
15. Samuelson TW, Katz LJ, Wells JM, Duh YJ, Giamporcaro JE,. Randomized evaluation of the trabecular micro-bypass stent with phacoemulsification in patients with glaucoma and cataract. Ophthalmology 2011; 118 (3): 459 - 67. 10544503
16. NCT01443988,. Subjects with open-angle glaucoma, pseudoexfoliative glaucoma, or ocular hypertension naïve to medical and surgical therapy, treated with two trabecular micro-bypass stents (iStent) or travoprost. clinicaltrials.gov/ct2/show/NCT01443988 (first received 30 September 2011). 10544505
17. Vold SD, Voskanyan L, Tetz M, Auffarth G, Masood I, Au L, et al., Erratum to: newly diagnosed primary open-angle glaucoma randomized to 2 trabecular bypass stents or prostaglandin: outcomes through 36 months. Ophthalmology and Therapy 2016; Vol. 5, issue 2: 173. 10544506
18. Vold SD, Voskanyan L, Tetz M, Auffarth G, Masood I, Au L, et al., Newly diagnosed primary open-angle glaucoma randomized to 2 trabecular bypass stents or prostaglandin: outcomes through 36 months. Ophthalmology and Therapy 2016; 5 (2): 161 - 72. 10544507
19. Bacharach J,. Efficacy of trabecular bypass stent through 2 years: data from the United States pivotal trial. Journal of Cataract and Refractive Surgery 2014; Vol. 40, issue 8: 1325 - 6. 10544509
20. NCT03274323,. Trabeculectomy versus 2-iStent and prostaglandin study (TIPS). clinicaltrials.gov/ct2/show/NCT03274323 (first received 6 September 2017). 10544511
21. Vlasov A, Kim WI,. The efficacy of two trabecular bypass stents compared to one in the management of open-angle glaucoma. Military Medicine 2017; 182 (S1): 222 - 5. 10544513
22. EUCTR2009-018066-36-ES,. Open prospective randomized evaluation of iStent® (GTS400) versus two ocular hypotensive agents in patients with primary open-angle glaucoma (Google translation) [Evaluación aleatorizada prospectiva en abierto del iStent® (GTS400) frente a dos agentes hipotensores oculares en pacientes con glaucoma primario de ángulo abierto-second line study]. apps.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2009-018066-36-ES (first received 11 March 2010). 10544515
23. NCT00326079,. A study of the Glaukos trabecular micro-bypass stent in open angle glaucoma subjects 1 stent versus 2. clinicaltrials.gov/ct2/show/study/NCT00326079 (first received 16 May 2016). 10544517
24. NCT01052558,. GTS400 stent implantation in conjunction with cataract surgery in subjects with open-angle glaucoma. clinicaltrials.gov/ct2/show/NCT01052558 (first received 20 January 2010). 10544519
25. NCT01252849,. Purpose of this study is to evaluate the safety and efficacy of one, two, or three iStents for the reduction of intraocular pressure in open-angle glaucoma subjects. clinicaltrials.gov/ct2/show/NCT01252849 (first received 3 December 2010). 10544521
26. NCT01444040,. Subjects with open-angle glaucoma, pseudoexfoliative glaucoma, or ocular hypertension naïve to medical and surgical therapy, treated with two trabecular micro-bypass stents (iStent inject) or travoprost. clinicaltrials.gov/ct2/show/NCT01444040 (first received 30 September 2011). 10544523
27. NCT01444105,. Open-angle glaucoma subjects on one ocular hypotensive medication randomized to treatment with two trabecular micro-bypass stents or selective laser trabeculoplasty. clinicaltrials.gov/ct2/show/NCT01444105 (first received 30 September 2011). 10544525
28. NCT01455467,. Open-angle glaucoma subjects on one topical hypotensive medication randomized to treatment with one or two trabecular micro-bypass stents in conjunction with cataract surgery. clinicaltrials.gov/ct2/show/NCT01455467 (first received 20 October 2011). 10544527
29. NCT01461291,. Multicenter study using Glaukos® trabecular micro-bypass stent model GTS400 using the G2-M-IS injector system in conjunction with cataract surgery. clinicaltrials.gov/ct2/show/NCT01461291 (first received 28 October 2011). 10544529
30. NCT02023242,. Comparing effectiveness of the Hydrus Microstent (TM) to two iStents to lower IOP in phakic eyes (COMPARE) [A prospective, multicenter, randomized comparison of the Hydrus to the iStent® for lowering intraocular pressure in primary open angle glaucoma]. clinicaltrials.gov/ct2/show/study/NCT02023242 (first received 30 December 2013). 10544531
31. NCT02024464,. Comparing Hydrus Microstent(TM) to the iStent for lowering IOP in glaucoma patients undergoing cataract surgery. clinicaltrials.gov/ct2/show/NCT02024464 (first received 31 December 2013). 10544533
32. NCT02327312,. Multicenter investigation of trabecular micro-bypass stents vs. laser trabeculoplasty. clinicaltrials.gov/ct2/show/NCT02327312 (first received 30 December 2014). 10544535
33. NCT03106181,. A comparison of cataract surgery alone and cataract surgery with iStent. clinicaltrials.gov/ct2/show/NCT03106181 (first received 10 April 2017). 10544537
34. UMIN000027734,. A randomized study of efficacy of trabecular micro bypass stent with cataract surgery for open angle glaucoma. upload.umin.ac.jp/cgi-open-bin/ctr-e/ctr-view.cgi?recptno=R000031775 first received 6 June 2017. 10544539
35. Prum BE Jr, Rosenberg LF, Gedde SJ, Mansberger SL, Stein JD, Moroi SE, et al., Primary open-angle glaucoma preferred practice pattern® guidelines. Ophthalmology 2016; 123 (1): P41 - P111.
36. AGIS investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. American Journal of Ophthalmology 2000; 130 (4): 429 - 40.
37. Allingham RR, Damji KF, Freedman SF, Moroi SE, Rhee DJ, Shields MB,. Shields Textbook of Glaucoma. 6th Edition. Philadelphia (PA): Wolters Kluwer Health/Lippincott Williams & Wilkins, 2010.
38. Bahler CK, Hann CR, Fjield T, Haffner D, Heitzmann H, Fautsch MP,. Second-generation trabecular meshwork bypass stent (iStent inject) increases outflow facility in cultured human anterior segments. American Journal of Ophthalmology 2012; 153 (6): 1206 - 13.
39. Brandao LM, Grieshaber MC,. Update on minimally invasive glaucoma surgery (MIGS) and new implants. Journal of Ophthalmology 2013; 2013: 705915. [DOI: 10.1155/2013/705915 ]
40. Caprioli J, Kim JH, Friedman DS, Kiang T, Moster MR, Parrish RK 2nd, et al., Special commentary: supporting innovation for safe and effective minimally invasive glaucoma surgery: summary of a joint meeting of the American Glaucoma Society and the Food and Drug Administration, Washington, DC, February 26, 2014. Ophthalmology 2015; 122 (9): 1795 - 801.
41. Veritas Health Innovation. Covidence. Version accessed prior to 25 April 2017. Melbourne: Veritas Health Innovation, 2015.
42. Deeks JJ, Higgins JP, Altman DG, editor(s) on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017), Cochrane, 2017. Available from handbook.cochrane.org.
43. European Glaucoma Society. Terminology and Guidelines for Glaucoma. 4th Edition. Savona: PubliComm, 2014.
44. Francis BA, Singh K, Lin SC, Hodapp E, Jampel HD, Samples JR, et al., Novel glaucoma procedures: a report by the American Academy of Ophthalmology. Ophthalmology 2011; 118 (7): 1466 - 80.
45. Friedman DS, Okeke CO, Jampel HD, Ying GS, Plyler RJ, Jiang Y, et al., Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma. Ophthalmology 2009; 116 (6): 1097 - 105.
46. Gedde SJ, Singh K, Schiffman JC, Feuer WJ,. The Tube Versus Trabeculectomy study: interpretation of results and application to clinical practice. Current Opinion in Ophthalmology 2012; 23 (2): 118 - 26.
47. Gedde SJ, Herndon LW, Brandt JD, Budenz DL, Feuer WJ, Schiffman JC,. Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up. American Journal of Ophthalmology 2012; 153 (5): 804 - 14.
48. Glanville JM, Lefebvre C, Miles JN, Camosso-Stefinovic J,. How to identify randomized controlled trials in MEDLINE: ten years on. Journal of the Medical Library Association 2006; 94 (2): 130 - 6.
49. Glaukos Corporation,. The iStent procedure. www.glaukos.com/istent (accessed on 27 June 2016).
50. GRADE Working Group, McMaster University. GRADEpro GDT. Version accessed prior to 14 January 2019. Hamilton (ON): GRADE Working Group, McMaster University, 2015.
51. Guyatt GH, Oxman AD, Montori V, Vist G, Kunz R, Brozek J, et al., GRADE guidelines: 5. Rating the quality of evidence-publication bias. Journal of Clinical Epidemiology 2011; 64 (12): 1277 - 82.
52. Higgins JP, Altman DG, Sterne JAC, editor(s),. Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017), Cochrane, 2017. Available from www.training.cochrane.org/handbook.
53. Hu K, Gazzard G, Bunce C, Wormald R,. Ab interno trabecular bypass surgery with Trabectome for open angle glaucoma. Cochrane Database of Systematic Reviews 2016, Issue 8. [DOI: 10.1002/14651858.CD011693.pub2 ]
54. King AJ, Shah A, Nikita E, Hu K, Mulvaney CA, Stead R, Azuara-Blanco A,. Subconjunctival draining minimally-invasive glaucoma devices for medically uncontrolled glaucoma. Cochrane Database of Systematic Reviews 2018, Issue 12. [DOI: 10.1002/14651858.CD012742 ]
55. Kirwan JF, Lockwood AJ, Shah P, Macleod A, Broadway DC, King AJ, et al., Trabeculectomy in the 21st century: a multicenter analysis. Ophthalmology 2013; 120 (12): 2532 - 9.
56. Klamann MK, Gonnermann J, Pahlitzsch M, Maier AK, Joussen AM, Torun N, et al., iStent inject in phakic open angle glaucoma. Graefe's Archive for Clinical and Experimental Ophthalmology 2015; 253 (6): 941 - 7.
57. Larsen CL, Samuelson TW,. Managing coexistent cataract and glaucoma with iStent. Survey of Ophthalmology 2017; Vol. 62, issue 5: 706 - 11. [DOI: 10.1016/j.survophthal.2016.01.006 ]
58. Lavia C, Dallorto L, Maule M, Ceccarelli M, Fea AM,. Minimally-invasive glaucoma surgeries (MIGS) for open angle glaucoma: a systematic review and meta-analysis. PloS One 2017; 12 (8): e0183142.
59. Le JT, Viswanathan S, Tarver ME, Eydelman M, Li T,. Assessment of the incorporation of patient-centric outcomes in studies of minimally invasive glaucoma surgical devices. JAMA Ophthalmology 2016; 134 (9): 1054 - 6.
60. Le JT, Rouse B, Gazzard G,. Iridotomy to slow progression of visual field loss in angle-closure glaucoma. Cochrane Database of Systematic Reviews 2018, Issue 6. [DOI: 10.1002/14651858.CD012270.pub2 ]
61. Le JT, Bicket, AK Tarver ME, Eydelman M, Li T,. Identifying and prioritizing outcomes that matter to patients considering minimally invasive glaucoma surgeries (MIGS) and other treatments for open-angle glaucoma. American Glaucoma Society Meeting; 2018 Mar 1-4; New York City (NY). 2018.
62. Leahy KE, White AJ,. Selective laser trabeculoplasty: current perspectives. Clinical Ophthalmology 2015; 9: 833 - 41.
63. Li T, Lindsley K, Rouse B, Hong H, Shi Q, Friedman DS, et al., Comparative effectiveness of first-line medications for primary open-angle glaucoma: a systematic review and network meta-analysis. Ophthalmology 2016; 123 (1): 129 - 40.
64. Lichter PR, Musch DC, Gillespie BW, Guire KE, Janz NK, Wren PA, et al., Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology 2001; 108 (11): 1943 - 53.
65. Malvankar-Mehta MS, Iordanous Y, Chen YN, Wang WW, Patel SS, Costella J, et al., iStent with phacoemulsification versus phacoemulsification alone for patients with glaucoma and cataract: a meta-analysis. PloS One 2015; 10 (7): e0131770.
66. Manasses DT, Au L,. The new era of glaucoma micro-stent surgery. Ophthalmology and Therapy 2016; 5 (2): 135 - 46.
67. Medeiros FA,. Biomarkers and surrogate endpoints in glaucoma clinical trials. British Journal of Ophthalmology 2015; 99 (5): 599 - 603.
68. National Eye Institute. Glaucoma, open-angle. nei.nih.gov/eyedata/glaucoma (accessed 27 October 2015).
69. National Institute for Health and Care Excellence. Glaucoma: diagnosis and management of chronic open angle glaucoma and ocular hypertension. www.nice.org.uk/guidance/CG85/chapter/1-Guidance#treatment-for-people-with-coag (accessed 5 June 2017).
70. Okeke CO, Quigley HA, Jampel HD, Ying GS, Plyler RJ, Jiang Y, et al., Adherence with topical glaucoma medication monitored electronically. The Travatan Dosing Aid study. Ophthalmology 2009; 116 (2): 191 - 9.
71. Otarola F, Hu K, Gazzard G, Bunce C,. Ab interno trabecular bypass surgery with Schlemḿs Canal Microstent (Hydrus) for open angle glaucoma. Cochrane Database of Systematic Reviews 2017, Issue 8. [DOI: 10.1002/14651858.CD012740 ]
72. Patel V, El Hawy E, Waisbourd M, Zangalli C, Shapiro DM, Gupta L, et al., Long-term outcomes in patients initially responsive to selective laser trabeculoplasty. International Journal of Ophthalmology 2015; 8 (5): 960 - 4.
73. Quigley HA, Broman AT,. The number of people with glaucoma worldwide in 2010 and 2020. British Journal of Ophthalmology 2006; 90 (3): 262 - 7.
74. Quigley HA, Friedman DS, Hahn SR,. Evaluation of practice patterns for the care of open-angle glaucoma compared with claims data: the Glaucoma Adherence and Persistency Study. Ophthalmology 2007; 114 (9): 1599 - 606.
75. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
76. Rolim de Moura C, Paranhos A Jr, Wormald R,. Laser trabeculoplasty for open angle glaucoma. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858.CD003919.pub2 ]
77. Spaeth GL, Cvintal V, Figueiredo A,. Is there a need for new surgical procedures for glaucoma? yes!. Open Ophthalmology Journal 2015; 9: 101 - 3.
78. Tarver M, Eyldelman M,. Incorporating patients' perspectives. glaucomatoday.com/2017/04/incorporating-patients-perspectives (accessed 15 April 2018).
79. Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY,. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 2014; 121 (11): 2081 - 90.
80. Tóth M, Shah A, Hu K, Bunce C, Gazzard G,. Endoscopic cyclophotocoagulation (ECP) for open angle glaucoma and primary angle closure. Cochrane Database of Systematic Reviews 2019, Issue 2. [DOI: 10.1002/14651858.CD012741 ]
81. Woo DM, Healey PR, Graham SL, Goldberg I,. Intraocular pressure-lowering medications and long-term outcomes of selective laser trabeculoplasty. Clinical and Experimental Ophthalmology 2015; 43 (4): 320 - 7.
82. Zhang ML, Hirunyachote P, Jampel H,. Combined surgery versus cataract surgery alone for eyes with cataract and glaucoma. Cochrane Database of Systematic Reviews 2015, Issue 7. [DOI: 10.1002/14651858.CD008671.pub3 ]